Primary Malignant Melanoma in the Pineal Region: Case Report and Literature Review
05 August 2017
29 November 2017
12 April 2018 (online)
Background Primary pineal malignant melanoma is a rare type of primary central nervous system melanoma with only 19 cases reported in the literature.
Case Report We present a case of a 53-year-old man with primary melanoma of the pineal region. He presented to the emergency department with gait unsteadiness and ataxia. Magnetic resonance imaging (MRI) revealed a 22 × 17 × 22-mm mass in the pineal region. On MRI the tumor was hyperintense in T1, isointense in T2, and on T1-weighted images with gadolinium enhancement it appeared homogeneously hyperintense with hypointense spots. Our patient underwent subtotal tumor resection as well as radiotherapy. The 52-week MRI control showed no recurrence of the lesion.
After 62 weeks he developed gait ataxia and headaches and was admitted to the emergency department. Computed tomography revealed tumor bleeding and obstructive hydrocephalus.
An external ventricular drain was placed, but the bleeding progressed, and 7 days after admission, MRI showed bleeding in the thalamus and mesencephalon. With a dismal prognosis, therapy was discontinued. He died 65 weeks after diagnosis.
Methods We reviewed the available literature (PubMed) with 19 published cases of primary pineal malignant melanoma and evaluated the common symptoms at presentation, histopathologic features, radiologic findings, therapeutic regimens, and time of survival to provide the most up-to-date treatment.
Results The median age of patients with primary pineal malignant melanoma is 52 years (female-to-male ratio: 10:10 years); a common first sign is chronic hydrocephalus. On MRI the lesion presents hyperintense in T1 and hypo- to isointense in T2. Biopsy or resection and histopathologic analysis are the key to diagnosis. Common histopathologic features are melanic pigment (n = 19/20), positive Human Melanoma Black (HMB-45) marker (n = 13/20), positive S100 protein reactivity (n = 11/20), as well as positive Melan-A (n = 9/20). The median survival was > 56.5 weeks in patients treated with resection and radiation.
Conclusion Reconsidering the reported cases surgical treatment followed by radiation increases the length of survival.
The patient in the study gave consent for the publication for this case report and any additional related information.
- 1 Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999; 43 (04) 795-803
- 2 Chiarion-Sileni V, Murr R, Pigozzo J, Sarti S, Tomassi O, Romanini A. Brain metastases from malignant melanoma. Forum (Genova) 2003; 13 (02) 170-182 ; quiz 190
- 3 Liubinas SV, Maartens N, Drummond KJ. Primary melanocytic neoplasms of the central nervous system. J Clin Neurosci 2010; 17 (10) 1227-1232
- 4 Mitchell PJ, Funt SA, Gonzales MF, Popovic EA. Primary pineal and meningeal malignant melanomatosis. J Clin Neurosci 1998; 5 (03) 353-356
- 5 Somers KE, Almast J, Biemiller RA, Silberstein HJ, Johnson MD, Mohile NA. Diagnosis of primary CNS melanoma with neuroimaging. J Clin Oncol 2013; 31 (01) e9-e11
- 6 Hayward RD. Malignant melanoma and the central nervous system. A guide for classification based on the clinical findings. J Neurol Neurosurg Psychiatry 1976; 39 (06) 526-530
- 7 Kennedy BC, Bruce JN. Surgical approaches to the pineal region. Neurosurg Clin N Am 2011; 22 (03) 367-380 , viii
- 8 Barron J, Morris-Larkin C, Finch T, Maroun F, Hache N, Yousef GM. Long survival of primary pineal melanoma with radiation treatment only. Can J Neurol Sci 2007; 34 (02) 251-253
- 9 Arlant PA, Grunnet ML, Heilbrun MP. Primary malignant melanoma of the pineal region. Surg Neurol 1977; 7 (03) 121-123
- 10 Weindling SM, Press GA, Hesselink JR. MR characteristics of a primary melanoma of the quadrigeminal plate. AJNR Am J Neuroradiol 1988; 9 (01) 214-215
- 11 Gaviani P, Mullins ME, Braga TA. , et al. Improved detection of metastatic melanoma by T2*-weighted imaging. AJNR Am J Neuroradiol 2006; 27 (03) 605-608
- 12 Brat DJ, Giannini C, Scheithauer BW, Burger PC. Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 1999; 23 (07) 745-754
- 13 Mohr P, Eggermont AM, Hauschild A, Buzaid A. Staging of cutaneous melanoma. Ann Oncol 2009; 20 (Suppl. 06) vi14-vi21
- 14 Weinstein D, Leininger J, Hamby C, Safai B. Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol 2014; 7 (06) 13-24
- 15 Cornejo KM, Hutchinson L, Cosar EF. , et al. Is it a primary or metastatic melanocytic neoplasm of the central nervous system?: a molecular based approach. Pathol Int 2013; 63 (11) 559-564
- 16 Yaeh A, Nanda T, Jani A. , et al. Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery. J Neurooncol 2015; 124 (03) 507-514
- 17 Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 2012; (09) CD006121
- 18 Brown PD, Jaeckle K, Ballman KV. , et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 2016; 316 (04) 401-409
- 19 Quirt I, Verma S, Petrella T, Bak K, Charette M. Temozolomide for the treatment of metastatic melanoma: a systematic review. Oncologist 2007; 12 (09) 1114-1123
- 20 Lee JM, Mehta UN, Dsouza LH, Guadagnolo BA, Sanders DL, Kim KB. Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report. Melanoma Res 2013; 23 (02) 175-178
- 21 Jetschke K, Viehweger H, Freesmeyer M, Warnke J-P, Mawrin C. Primary pineal malignant melanoma with B-Raf V600E mutation: a case report and brief review of the literature. Acta Neurochir (Wien) 2015; 157 (07) 1267-1270
- 22 Long GV, Trefzer U, Davies MA. , et al. Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial. Lancet Oncol 2012; 13 (11) 1087-1095
- 23 Park J-H, Hong Y-K. Primary malignant melanoma in the pineal region. J Korean Neurosurg Soc 2014; 56 (06) 504-508
- 24 Enriquez R, Egbert B, Bullock J. Primary malignant melanoma of central nervous system. Pineal involvement in a patient with nevus of ota and multiple pigmented skin nevi. Arch Pathol 1973; 95 (06) 392-395
- 25 Carlson BR, Glick AD, Cushman AR. Primary malignant melanoma of pineal region. J Tenn Med Assoc 1987; 80 (10) 597-599
- 26 Rubino GJ, King WA, Quinn B, Marroquin CE, Verity MA. Primary pineal melanoma: case report. Neurosurgery 1993; 33 (05) 511-515 ; discussion 515
- 27 Yamane K, Shima T, Okada Y. , et al. Primary pineal melanoma with long-term survival: case report. Surg Neurol 1994; 42 (05) 433-437
- 28 Suzuki T, Yasumoto Y, Kumami K. , et al. Primary pineal melanocytic tumor. Case report. J Neurosurg 2001; 94 (03) 523-527
- 29 Bookland M, Anderson WS, Biser-Rohrbaugh A, Jallo GI. Primary pineal malignant melanoma. Pediatr Neurosurg 2007; 43 (04) 303-308
- 30 Martin-Blondel G, Rousseau A, Boch AL, Cacoub P, Sène D. Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature. Clin Neuropathol 2009; 28 (05) 387-394
- 31 Arantes M, Castro AF, Romão H. , et al. Primary pineal malignant melanoma: case report and literature review. Clin Neurol Neurosurg 2011; 113 (01) 59-64
- 32 Cedeño Diaz OM, Leal RG, La Cruz Pelea C. Primary pineal malignant melanoma. Clin Pract 2011; 1 (02) e31
- 33 Azimi P, Mohmmadi HR, Refiezadeh M. Primary pineal melanoma presenting with leptomeningeal spreading in a 22-year-old woman: a case report. J Med Case Reports 2012; 6 (01) 165
- 34 Shinsato Y, Hanada T, Kisanuki T. , et al. Primary malignant melanoma in the pineal region treated without chemotherapy. Surg Neurol Int 2012; 3: 123
- 35 Biswas A, Chaudhari PB. , M SK, et al. Primary pineal malignant melanoma - illustrated review. Turk Neurosurg 2015; 25 (02) 201-209